NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 27 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,128 | +2.1% | 500,000 | 0.0% | 0.01% | +18.2% |
| Q2 2023 | $462,430 | -1.6% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $470,000 | +2.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $458,750 | -3.0% | 500,000 | 0.0% | 0.01% | -8.3% |
| Q3 2022 | $473,000 | +1.5% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $466,000 | -13.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $541,000 | -2.7% | 500,000 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $556,000 | -17.6% | 500,000 | 0.0% | 0.01% | -7.1% |
| Q3 2021 | $675,000 | -22.1% | 500,000 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $866,000 | +12.3% | 500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $771,000 | -15.5% | 500,000 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $912,000 | +17.7% | 500,000 | 0.0% | 0.02% | -5.0% |
| Q3 2020 | $775,000 | +13.5% | 500,000 | 0.0% | 0.02% | +5.3% |
| Q2 2020 | $683,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 9,000,000 | $135,324,000 | 1.71% |
| DeepCurrents Investment Group LLC | 21,930,000 | $33,750,000 | 1.16% |
| WOLVERINE ASSET MANAGEMENT LLC | 44,534,000 | $69,564,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,208,000 | 0.38% |
| Context Capital Management, LLC | 2,000 | $3,084,000 | 0.30% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $2,276,000 | 0.27% |
| Polar Asset Management Partners Inc. | 17,500,000 | $26,683,000 | 0.26% |
| CSS LLC/IL | 2,500,000 | $3,780,000 | 0.16% |
| Verition Fund Management LLC | 7,486,000 | $11,543,000 | 0.13% |
| PFM Health Sciences, LP | 2,000,000 | $3,032,000 | 0.09% |